A study in wild-type and liver-specific DPP-4 transgenic mice showed that subjects suffering from NAFLD exhibit elevated plasma DPP-4 activity what is associated with diminished glucose-induced active GLP-1 levels [140]. The gene discussed is GLP1R; the disease is metabolic dysfunction-associated steatotic liver disease.